Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of the Causes and Disease Processes of Chronic Lung Disease
This study is currently recruiting participants.
Study NCT00001183   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: September 4, 2009   History of Changes

November 3, 1999
September 4, 2009
March 1982
 
 
 
Complete list of historical versions of study NCT00001183 on ClinicalTrials.gov Archive Site
 
 
 
Evaluation of the Causes and Disease Processes of Chronic Lung Disease
Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease (Screening Protocol)

Chronic lung diseases are disorders associated with abnormalities in any of the structures involved in the process of breathing and bringing oxygen into the lungs and blood. This includes abnormalities in the airways, lungs, blood vessels in and around the lungs, and the tissue covering the lungs (pleura).

The purpose of this research study is to evaluate patients referred to the Pulmonary-Critical Care Medicine Branch (P-CCMB) of the National Heart, Lung, and Blood Institute (NHLBI) in order to;

  1. Develop a better understanding of the causes and disease processes involved in disorders of the lungs
  2. Identify patients eligible to participate in other P-CCMB research studies

The chronic lung diseases are those disorders associated with functional and/or structural derangement to the alveolar structures, airways, pulmonary blood vessels, pleura and/or mediastinum. The purpose of this project is to permit the comprehensive evaluation of patients referred to the Translational Medicine Branch or Pulmonary and Vascular Medicine Branch the National Heart, Lung and Blood Institute (NHLBI) in order to: (1) develop an understanding of the etiology and pathogenesis of these disorders; and (2) identify individuals who will be suitable candidates for other NHLBI protocols.

 
Observational
 
Lung Disease
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
99999999
 
 
  • INCLUSION CRITERIA:

Symptoms consistent with pulmonary disease.

May have family history of lung disease.

Patients with diseases of organs with known association with lung disease.

EXCLUSION CRITERIA:

Persons with no clinical evidence of lung disease.

Both
10 Years and older
No
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010
United States
 
NCT00001183
 
820032, 82-H-0032
National Heart, Lung, and Blood Institute (NHLBI)
 
 
National Institutes of Health Clinical Center (CC)
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP